Physician profile
Sanjeev Sethi
NPI 1083694855
$52,610.47
in general payments reported to CMS, 2019-2025
6 companies · $9,820 in 2025
The $9,820 reported for 2025 was more than what 95% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12K · 2021: $10K · 2022: $2,588 · 2023: $6,113 · 2024: $12K · 2025: $9,820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Food and Beverage: $705 · Travel and Lodging: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,611.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Food and Beverage | $704.52 |
| Travel and Lodging | $207.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $39,854.30 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $5,028.57 | 2024-2025 | |
| Amgen INC. | $3,750.00 | 2025 | Uplizna |
| Travere Therapeutics, INC. | $2,790.60 | 2023-2024 | |
| Biocryst Pharmaceuticals, INC. | $637.00 | 2023 | |
| Argenx US, INC. | $550.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.